Progressive Cutaneous T-cell lymphoma

Drug	Drug Name	Drug Description
DB02546	Vorinostat	A histone deacetylase (HDAC) inhibitor used for the treatment of cutaneous manifestations in patients with progressive, persistent, or recurrent cutaneous T- cell lymphoma (CTCL) following prior systemic therapies.

Drug	Drug Name	Target	Type
DB02546	Vorinostat	Histone deacetylase 1	target
DB02546	Vorinostat	Histone deacetylase 2	target
DB02546	Vorinostat	Histone deacetylase 3	target
DB02546	Vorinostat	Histone deacetylase 6	target
DB02546	Vorinostat	Histone deacetylase 8	target
DB02546	Vorinostat	Acetoin utilization protein	target
DB02546	Vorinostat	Histone deacetylase	target

Drug	Drug Name	Phase	Status	Count